Glaukos

-$1.51 (-3.73%) Today
$0.00 (0.00%) As of 10:47 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.

CEO
Thomas William Burns
Employees
727
Headquarters
San Clemente, California
Founded
1998

GKOS Key Statistics

Market cap
1.84B
Price-Earnings ratio
—
Dividend yield
—
Average volume
493.97K
High today
$40.03
Low today
$38.51
Open price
$39.88
Volume
407.75K
52 Week high
$87.24
52 Week low
$33.33

GKOS Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure